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Abstract
Background: In a home telemonitoring trial, patient adherence with scheduled vital signs measurements is an important aspect
that has not been thoroughly studied and for which data in the literature are limited. Levels of adherence have been reported as
varying from approximately 40% to 90%, and in most cases, the adherence rate usually dropped off steadily over time. This drop
is more evident in the first few weeks or months after the start. Higher adherence rates have been reported for simple types of
monitoring and for shorter periods of intervention. If patients do not follow the intended procedure, poorer results than expected
may be achieved. Hence, analyzing factors that can influence patient adherence is of great importance.
Objective: The goal of the research was to present findings on patient adherence with scheduled vital signs measurements in
the recently completed Commonwealth Scientific and Industrial Research Organisation (CSIRO) national trial of home
telemonitoring of patients (mean age 70.5 years, SD 9.3 years) with chronic conditions (chronic obstructive pulmonary disease,
coronary artery disease, hypertensive diseases, congestive heart failure, diabetes, or asthma) carried out at 5 locations along the
east coast of Australia. We investigated the ability of chronically ill patients to carry out a daily schedule of vital signs measurements
as part of a chronic disease management care plan over periods exceeding 6 months (302 days, SD 135 days) and explored different
levels of adherence for different measurements as a function of age, gender, and supervisory models.
Methods: In this study, 113 patients forming the test arm of a Before and After Control Intervention (BACI) home telemonitoring
trial were analyzed. Patients were required to monitor on a daily basis a range of vital signs determined by their chronic condition
and comorbidities. Vital signs included noninvasive blood pressure, pulse oximetry, spirometry, electrocardiogram (ECG), blood
glucose level, body temperature, and body weight. Adherence was calculated as the number of days during which at least 1
measurement was taken over all days where measurements were scheduled. Different levels of adherence for different measurements,
as a function of age, gender, and supervisory models, were analyzed using linear regression and analysis of covariance for a
period of 1 year after the intervention.
Results: Patients were monitored on average for 302 (SD 135) days, although some continued beyond 12 months. The overall
adherence rate for all measurements was 64.1% (range 59.4% to 68.8%). The adherence rates of patients monitored in hospital
settings relative to those monitored in community settings were significantly higher for spirometry (69.3%, range 60.4% to 78.2%,
versus 41.0%, range 33.1% to 49.0%, P<.001), body weight (64.5%, range 55.7% to 73.2%, versus 40.5%, range 32.3% to 48.7%,
P<.001), and body temperature (66.8%, range 59.7% to 73.9%, versus 55.2%, range 48.4% to 61.9%, P=.03). Adherence with
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blood glucose measurements (58.1%, range 46.7% to 69.5%, versus 50.2%, range 42.8% to 57.6%, P=.24) was not significantly
different overall. Adherence rates for blood pressure (68.5%, range 62.7% to 74.2%, versus 59.7%, range 52.1% to 67.3%, P=.04),
ECG (65.6%, range 59.7% to 71.5%, versus 56.5%, range 48.7% to 64.4%, P=.047), and pulse oximetry (67.0%, range 61.4%
to 72.7%, versus 56.4%, range 48.6% to 64.1%, P=.02) were significantly higher in males relative to female subjects. No statistical
differences were observed between rates of adherence for the younger patient group (70 years and younger) and older patient
group (older than 70 years).
Conclusions: Patients with chronic conditions enrolled in the home telemonitoring trial were able to record their vital signs at
home at least once every 2 days over prolonged periods of time. Male patients maintained a higher adherence than female patients
over time, and patients supervised by hospital-based care coordinators reported higher levels of adherence with their measurement
schedule relative to patients supervised in community settings. This was most noticeable for spirometry.
Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12613000635763;
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364030&isReview=true (Archived by WebCite at
http://www.webcitation.org/6xPOU3DpR).
(JMIR Med Inform 2018;6(2):e15)   doi:10.2196/medinform.9200
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Introduction
Telehealth, the delivery of health services at a distance, has been
extensively studied in various at-home, primary care, and
hospital-based settings for more than 20 years [1-5]. Large
health care organizations such as the Veterans Administration
in the United States or the National Health Service in the United
Kingdom have already adopted a range of telehealth solutions
[6]. The aging population and increasing burden of chronic
disease together with the availability of low-cost monitoring
technology have resulted in increasing interest in deploying
telehealth services for the management of patients with chronic
conditions and an increasing market demand worldwide for
telehealth services.
Different aspects of telehealth solutions, such as clinical, service,
and economic benefits, have been investigated in several pilot
projects [7,8]. These factors need to be evaluated in order to
promote wide-scale implementation and reduce costs. However,
patient adherence with scheduled vital signs measurements or
their use of technology is an important aspect that has not been
thoroughly studied. As patients in home telehealth programs
may choose to stop their participation [9] or may not follow the
intended procedure, poorer results than expected may be
achieved [10]. In order to gain the maximum benefits of at-home
telehealth services, adherence rates should be high. Hence,
analyzing factors that can influence patient adherence is of great
importance.
Relatively few randomized controlled trials on at-home
telemonitoring of vital signs have been reported [3,11]. This
paper reports findings on patient adherence in the recently
completed Commonwealth Scientific and Industrial Research
Organisation (CSIRO) trial of home monitoring for chronic
disease management, carried out at several locations along the
east coast of Australia [12]. The trial was designed to explore
a wide set of outcomes resulting from the introduction of a
telehealth model of service based on at-home telemonitoring of
vital signs and administration of a range of clinical
questionnaires to patients with a range of chronic conditions
supervised in either hospital-based or community-based settings.
The clinical protocols for the trial [12], the data architecture
design [13], decision support and statistical trend analysis of
vital signs data [14], and the impact of telemonitoring on health
care expenditure, hospital admissions, and length of stay [8]
have been previously published.
In hospital intensive care units, it is well recognized that serious
adverse events can be prevented [15-20] by recognizing early
warning signs of clinical and physiological deterioration and
responding appropriately. The authors concluded that early
recognition of these events presents an opportunity for
decreasing mortality. There is thus a clear analogy between the
use of early warning systems in intensive care units and
emergency departments and the early warning that is available
through the longitudinal monitoring of vital signs at home of
chronically ill individuals.
However, there is currently limited knowledge about the
influences and determinants of home telehealth adherence in
frail elderly people and their carers [21,22]. Their ability to
adhere to a strict regime of telemonitoring has been identified
as an important influence on the success of telemonitoring
programs [23], and there is a perception that patients will not
adhere to a monitoring protocol and will often abandon the
program [24,25].
A systematic review of the uptake and continued use of
telehealth for patients with congestive heart failure (CHF) and
chronic obstructive pulmonary disease (COPD) [26] reported
that almost one-third of patients who were offered telehealth
services refused and one-fifth of patients who did accept
subsequently withdrew. Other studies on the adherence and
effectiveness of at-home telemonitoring [27] report that over 1
year the adherence rate for recording weight was 75% and for
the recording of blood pressure, 90%, while another study [28]
reported values of 12% to 75% for adherence with daily
weighing for CHF patients. According to Maeder et al [6],
reported levels of adherence varied from approximately 40%
to 90%. In most of these studies, the adherence rate usually
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dropped off steadily over time. This drop is more evident in the
first few weeks or months after the start. Higher adherence rates
have been reported for simple types of monitoring and for
shorter periods of intervention [6]. As an illustration, while
adherence rates of 89% were reported by Port et al [29] for the
first 2 months, this rate dropped to around 50% within 10
months. The adherence rate in a more complex monitoring
system after lung transplantation was about 42% [30].
In this paper we undertake a comprehensive analysis of patient
adherence with their measurement schedules in the CSIRO
National Telehealth Trial, driven by the hypothesis that
longitudinal vital signs data and periodic patient-administered
clinical questionnaires provide powerful tools for early
identification of an exacerbation of a patient’s condition and
permit the early mobilization of clinical resources to avoid
unnecessary hospitalization.
Methods
Research Ethics Committee Approval
The clinical trial protocol for this study was approved by the
CSIRO Human Research Ethics Committee (approval number
13/04, March 25, 2013) as well as 5 other state- and site-based
local ethics committees.
Patient Selection
A master register of 1429 eligible patients was formed from
hospital lists provided by local health districts and patients
known to clinical staff. Local health districts were located in
the states of Queensland (QLD), New South Wales (NSW), the
Australian Capital Territory (ACT), Victoria (VIC), and
Tasmania (TAS). Subjects were eligible to participate in the
study if they met inclusion criteria that were comprehensively
described in an earlier publication [11] but mentioned briefly
here for convenience: age 50 years and older; 2 or more
unplanned acute admissions during the last 12 months or 4 or
more unplanned acute admissions during the previous 5 years;
and a principal diagnosis of COPD, coronary artery disease,
hypertensive diseases, CHF, diabetes, or asthma. From the
master register, 479 patients were still deemed eligible after
individual screening and were contactable. Patients were deemed
ineligible if they had been diagnosed with compromised
cognitive function, a neuromuscular disease, cancer, or a
psychiatric condition. Note that we chose to take a population
health approach to patient selection in that all patients who met
the inclusion criteria were eligible, irrespective of their chronic
condition. As a result, the patient cohort is subsequently treated
as a homogenous group in this paper.
As reported in Celler et al [8], of the 479 eligible patients, 128
(26.7%) declined to participate, 41 patients did not meet
inclusion criteria at interview, and 23 were unable to commence.
Of the remaining 287 subjects who consented, 114 were
randomly allocated to the telemonitoring test group and the
remaining 173 were allocated to the control group (Figure 1).
In addition, it was found that vital sign records for 1 subject
were missing. Test patients were supplied with a telemonitoring
system and trained on its use on installation, while the control
group continued to receive normal care through their primary
care physician.
Figure 1. Final cohort of test and control patients.
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A project officer at each test site was responsible for managing
operational and research activities for the study, thereby
separating patient care from study operations. The PO was also
responsible for consenting patients, onsite visits, equipment
maintenance, and technical support.
The clinical care coordinators (CCCs) were experienced nursing
staff, seconded part-time from each trial site health service
provider. In 2 of the 5 trial sites, the CCCs were specialist nurses
based in local hospitals and able to draw upon the clinical
resources of the hospital. The remaining 3 sites were community
sites located within primary care organizations called Medicare
Locals. In these sites, the CCCs were community nurses with
little access to additional clinical resources other than the
patients’ own primary care provider.
The CCCs monitored patients’ vital signs and clinical
questionnaire responses recorded via the telemonitoring unit
daily during business hours. In response to exacerbations in
their patients’ conditions, as evidenced by changes in the
patients’ vital signs and questionnaire responses, CCCs would
initiate and coordinate a timely response to avoid a further
exacerbation of their condition and possible hospitalization.
Time spent by patients taking their vital signs at home and time
spent by CCCs in managing the patients under their care was
monitored by comprehensive logs routinely collected by the
telemonitoring system and clinician portal. CCCs could also
report time spent on a professional portal set up to provide a
chat room for CCCs and POs.
Vital Signs Telemonitoring Unit
The TeleMedCare (TMC) Systems Clinical Monitoring Unit
(TeleMedCare Pty Ltd), depicted in Figure 2, and associated
data hosting and clinical web services were selected for the trial;
not all features offered by the device were used in this study.
The selection of this telemonitoring system was based on the
requirements listed below:
• All vital sign measuring devices are part of the system,
minimizing issues that can happen by having separate
devices connecting to a central unit
• Entire telemonitoring system together with measuring
devices and software are approved by the Australian
Therapeutic Goods Administration and the US Food and
Drug Administration
• Telemonitoring system has no battery requirements as the
unit is mains powered
• No incompatibility and calibration issues given the unit is
designed to work together with all its devices
• Must be user friendly and easy to operate
• All these factors including subscription costs fit within the
time and budget of the trial
The site POs and CCCs configured the telemonitoring system
to reflect clinical best practice for the patient’s clinical condition.
Patients would be reminded to record some or all of the vital
signs shown below, typically in the morning before taking their
medications.
• Noninvasive blood pressure (NIBP) using combined
oscillometric and auscultatory techniques
• Pulse oximetry to measure arterial blood oxygen saturation
• Single channel ECG, using either the built-in surface
electrodes or a custom cable and electrode clamps
• Spirometry, including measurements of vital capacity, peak
expiratory flow rate, and volume expired in first second
• Body temperature
• Body weight (SD 100 gm accuracy)
• Glucometer (blood glucose concentration)
In addition to their schedule, patients could take their vital signs
at any time. A full suite of clinical questionnaires was also
available. These were scheduled and administered by the CCCs
and POs.
Monitoring of Vital Signs
Patients were encouraged to record their vital signs daily. CCCs
generally viewed every patient’s record daily, and time spent
on each patient was tracked using the CSIRO Web portal and
logs implemented on the clinician portal. On average, CCCs
accessed the TMC Clinician Web Portal a little more than once
a day and spent on average a little less than 30 minutes per week
reviewing each patient’s data. There was no significant
difference in the time spent by community-based and
hospital-based CCCs in the time spent reviewing patient data.
CCCs were able to make contact with patients at will to review
their progress and discuss the data collected.
Not all patients were required to measure all vital signs. Patients
were required to measure vital signs according to their primary
disease condition and known comorbidities. Thus 111 patients
were monitoring blood pressure, 111 patients were monitoring
their peripheral capillary oxygen saturation (SpO2), 113 patients
were recording their ECG, 52 were recording their blood
glucometry, 78 were monitoring their respiratory function, 95
were monitoring their body weight, and 103 were recording
their body temperature.
Patients’ adherence with their scheduled daily measurements
was calculated by tracking the total number of scheduled events
and then counting the actual number of measurement activities
completed. Multiple measurements taken on any 1 day are
counted as a single measurement. The ratio of these provides a
robust measure of adherence.
Statistical Analysis
Comparisons using the cases available were made between
subgroups using the 2-sample t test for continuous variables
and the Wilcoxon rank-sum test for skewed variables. Baseline
characteristics are described using mean and SD for continuous
symmetrical variables and mean and 95% CI for skewed data.
Categorical variables are presented as counts and percentages.
All statistical tests were 2-tailed, and a P value of <.05 was used
to indicate statistical significance. Statistical analysis was
performed using MATLAB R2016b (MathWorks) and Excel
(Microsoft).
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Linear regression was carried out using the fit command in the
MATLAB statistics toolbox, and 1-way analysis of covariance
(ANCOVA) was used to determine whether the slopes of the
linear regression lines are different for the average adherence
rates associated with blood pressure, ECG, SpO2, blood glucose,
body temperature, and body weight for male and female patients.
Synchronization of Data to Start Date of
Telemonitoring
In this study, time is not calendar time but rather time relative
to each patient’s start date of telemonitoring. This compensates
for the fact that individual patients were enrolled and
commenced telemonitoring over a period of more than a year
(Figure 3) and helps to attenuate seasonal effects.
Figure 2. TeleMedCare clinical monitoring unit.
Figure 3. Distribution of commencement dates for monitoring of vital signs.
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Demographics of Test Patients
Basic demographics of test patients in the study are shown in
Table 1. There were no significant differences in age between
test patients in each of the 5 sites and between male and female
patients.
A total of 63.7% (72/113) of the test patients were male and
36.3% (41/113) were female. Most test patients had more than
1 condition listed as a primary diagnosis, and for simplicity,
primary disease conditions were grouped in the broad categories
of cardiovascular disease (NTest=58), respiratory disease
(NTest=34), and diabetes (NTest=21). Figure 3 shows the wide
distribution of commencement dates for the test patients arising
from local operational delays in identifying patients and
providing access to the Internet.
Test patients were monitored on average for 302 days, with no
significant difference between average monitoring durations
for female patients (287 days) and male patients (310 days);
75% of all test patients were monitored for periods exceeding
6 months. The duration of monitoring for patients who did not
drop out was primarily determined by the individual start date
of the intervention and the end date of the trial.
Patient Adherence With Monitoring Schedules
Overall patient adherence data is shown in Table 2. Test patients
successfully completed 120,861 measurements of vital signs
over a period of 16 months and on average, patients were
recording their vital signs with an adherence rate of 64.78%, a
little better than once every 2 days.
Patients under the care of community-based CCCs were overall
a little less adherent than patients under the care of
hospital-based CCCs (63,553/103,737, 61.26%, versus
56,598/81,821, 69.17%). However, adherence with forced
spirometry, body temperature, and body weight measurements
was substantially greater for patients under hospital-based
supervision than for patients supervised in the community. These
differences are further explored in the next section.
Adherence Rates Over Time by Age, Gender, and
Mode of Supervision
We now explore differences in adherence rates over time
synchronized to the start date of telemonitoring for each patient
and between male and female patients and younger and older
patients and further analyze the differences observed between
hospital-based supervision and community-based supervision.
In this analysis, we have only included patients who finished
at least 3 months of measurements.




70.5 (9.3)70.0 (10.8)76.7 (9.1)68.9 (7.6)70.1 (8.2)68.8 (9.0)Age, years (SD)
72169181118Male patients, n
70.1 (8.6)69.4 (9.0)75.4 (7.4)69.5 (7.8)69.9 (7.7)68.9 (10.0)Age, years (SD)
411087511Female patients, n
70.1 (8.6)70.9 (13.6)78.1 (11.2)67.4 (7.4)70.6 (10.2)68.6 (7.4)Age, years (SD)
aTAS: Tasmania.
bACT: Australian Capital Territory.
cVIC: Victoria.
dNSW: New South Wales.
eQLD: Queensland.
Table 2. Patient adherence with measurement.
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We note that in the first quarter of monitoring (see Multimedia
Appendix 1), the adherence rates of patients monitored in
hospital settings relative to those monitored in community
settings were significantly higher for spirometry, blood glucose,
body weight, and body temperature. Adherence rates for other
measurements and differences in adherence across age and
gender were not significantly different.
In the second quarter, significantly higher adherence rates for
blood glucose, spirometry, body weight, and body temperature
continued to be observed for patients supervised in hospital
settings relative to those supervised in community settings, and
male adherence with NIBP, SpO2, and ECG began to
significantly increase relative to female adherence. Adherence
with spirometry measurements for the patient cohort older than
70 years also increased significantly (P=.049) relative to the 70
years and younger patient cohort.
In the third quarter, males continue to be more adherent than
females for NIBP and SpO2 measurements, and
hospital-supported patients continued to be more adherent than
community-supported patients for spirometry measurements.
In the fourth quarter, those aged over 70 years were more
adherent than those aged 70 years and younger for spirometry
measurements, and males continue to be more adherent than
female patients for NIBP, SpO2, ECG, and BT. Differences in
adherence rates for spirometry between hospital-supported
patients (74%, range 64.5% to 83.5%) and community-supported
patients (38.6%, 28.6% to 49.1%) become even more
pronounced (P=.002).
Linear Regression Analysis of Changes in Adherence
Over Time
Linear regression was carried out as described in the Methods
section with the results shown in Figures 3-5 and Table 3. When
adherence rates initially dropped off in the first 2 months of
monitoring, these data were removed and analyzed separately
to identify long-term trends. ANCOVA analysis comparing
slope of the overall male and female adherence data in Figure
4 confirms that there was a significant (P=.002) difference in
the slopes.
A similar analysis was undertaken for subgroups within the total
patient cohort to test whether these results were different for
those who were monitored within a community environment or
within a hospital environment. In Figure 5, a significant
difference (P=.02) in slopes for hospital-supervised patients
compared with community-supervised patients is observed
although the latter appear to increase their adherence over time.
We undertook a similar analysis to test whether these results
were different for younger patients (aged 70 years and younger)
and older patients (older than 70 years) and for patients with
predominantly cardiovascular disease and those with other
diseases. Our analysis, however, showed that there were no
significant differences between these subgroups.
The spirometry adherence rate (Table 4) was an outlier in this
analysis in that no significant difference was seen between male
and female adherence rate variation over time. However, as
shown in Figure 6, while patients supervised in a hospital setting
had far higher adherence rates that indeed increased over time,
the adherence rates for community-supported patients started
at a much lower level and then decreased over time.
Figure 4. Average adherence rates over time by gender (combined blood pressure, electrocardiogram, peripheral capillary oxygen saturation, blood
glucose, body temperature, and body weight). Red lines are linear regression lines (the given equations represent the regression lines).
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Figure 5. Average adherence rates over time by community-based or hospital-based mode of supervision (blood pressure, electrocardiogram, peripheral
capillary oxygen saturation, blood glucose, body temperature, and body weight). Red lines are linear regression lines (the given equations represent the
regression equations).
Table 3. Linear regression and analysis of covariance for different subgroups within the total patient cohort.
P valueIntercept, % (95% CI)Slope, %/month (95% CI)Patient subgroups
.0269.02 (59.05 to 78.79)1.86 (–0.01 to 3.72)Male patients
—a61.42 (51.45 to 71.40)–0.38 (–2.25 to 1.49)Female patients
.0277.03 (69.53 to 84.53)0.08 (–1.32 to 1.49)Hospital-based patients
—57.86 (50.36 to 65.37)1.87 (0.47 to 3.28)Community-based patients
.2567.90 (60.51 to 70.30)0.63 (–0.75 to 2.02)Patients 70 years and younger
—65.21 (57.82 to 72.61)1.40 (0.02 to 2.79)Patients older than 70 years
.0768.10 (59.08 to 77.12)1.53 (–0.16 to 3.22)Cardiac patients
—66.04 (57.02 to 75.07)–0.01 (–1.70 to 1.68)Patients with other chronic conditions
aIndicates data is not applicable.
Table 4. Linear regression and analysis of covariance for spirometry adherence.
P valueIntercept, % (95% CI)Slope, %/month (95% CI)Patient subgroups
.8855.02 (45.64 to 64.41)1.81 (0.05 to 3.57)Male patients
—a48.40 (27.86 to 68.93)1.53 (–2.31 to 5.38)Female patients
<.00175.71 (67.85 to 83.58)1.67 (0.19 to 3.14)Hospital-based patients
—35.06 (28.87 to 41.26)–1.84 (–3.00 to –0.68)Community-based patients
aIndicates data is not applicable.
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Figure 6. Spirometry adherence rates over time by mode of community-based or hospital-based supervision. Red lines are linear regression lines (the
given equations represent the regression lines).
Discussion
Principal Findings
We present in this paper some fundamental results on the ability
and willingness of chronically ill patients to engage with a
comprehensive regime of at-home telemonitoring of their vital
signs over extended periods of time, in some cases exceeding
a year. In our study there were no significant differences in
health literacy, socioeconomic status, or level of previous
experience with technology. We recognize that different vital
signs are easier and more acceptable than others to carry out,
and we anticipated that overall adherence rates would reflect
the ease of use and perceived value of the measurement. Overall
adherence rates were, however, surprisingly similar, ranging
from 56.1% for spirometry to 70.4% for blood pressure
measurements. This is consistent with the relative complexity
of spirometry measurements, which require 3 forced expiratory
efforts and could be quite tiring for frail, chronically ill patients.
Our results straddle levels of adherence reported by Maeder [6]
of between 40% to 90% and do show an initial steady drop-off
over time, particularly in the first few weeks or months after
the start. Unlike Port et al [29], who reported that an initial
adherence rate of 89% dropped to around 50% within 10 months,
our study shows an increase in adherence following an initial
drop. Our study also confirms that higher adherence rates are
reported for simple types of monitoring and for shorter periods
of intervention [6].
Generally, adherence with measurement of vital signs fell over
the first 3 months (Multimedia Appendix 1 and Figures 4 and
5) but recovered over time to levels achieved at the start of
monitoring. As a result, there were no significant differences
between adherence rates recorded in the first quarter of
monitoring and those recorded in the last quarter of monitoring.
Measurement of spirometry by women, however, started from
a very low level and continued to fall over time (Figure 6). Age
did not appear to be a factor, as there were no significant
differences between adherence rates of those aged 70 years and
younger and those older than 70 years. Gender, however, was
a factor, as male subjects were more adherent than female
patients across all measurement modalities. The differences
were only significant for the measurement of NIBP, SpO2, and
ECG (Multimedia Appendix 1). These data on gender
differences are in good agreement with the literature, which
reports reduced adherence by women to telemonitoring of BP
[30], antiretroviral therapies [31], management of cystic fibrosis
[32], and medications [33].
In 2 of our sites, care coordination was hospital-based and was
carried out by highly trained specialist nurses. In the other 3
sites, care coordination was carried out by community nurses
often without any additional clinical support. Patients supported
by hospital-based care coordinators were significantly more
adherent with their measurement of lung function (spirometry),
blood glucose, body weight, and body temperature than those
supported by community-based care coordinators. Adherence
was also higher for patients supported by hospital-based care
coordination for NIBP, SpO2, and ECG, but the differences
were not significant.
We cannot fully explain the initial fall of adherence in the first
quarter other than to hypothesize that CCCs may be more
successful in encouraging patients to continue with their
measurements once a longitudinal patient record is achieved
and its value noted. The other major conclusion of this study is
that care coordination by hospital-based staff leads to higher
levels of adherence than for patients managed by
community-based staff. This would suggest that hospital-based
staff may be more cognizant of the benefits of monitoring vital
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signs, more capable of interpreting the longitudinal patient
record, and therefore more willing to offer greater
encouragement and support to their patients.
According to the systematic review undertaken by Maeder et
al [6], the adherence rate usually dropped off steadily over time
in most of the studies, and this drop is more evident in the first
few weeks or months after the start. Although it is evident from
our results that the overall adherence rate dropped off in the
first 3 month, it did not continue to fall and indeed recovered
over time. We can therefore conclude that chronically ill patients
are able to monitor their vital signs at least once every 2 days
over prolonged periods of time even for the most difficult
measurements such as spirometry and ECG.
Our results also found that the adherence rates in male and
community-based subgroups of patients significantly increased
over time while the adherence rates in female and hospital-based
patients slightly decreased over time. Additionally, the
adherence rate variations over time were not significantly
different between younger and older subgroups within the total
patient cohort or between patients with predominantly
cardiovascular disease and those with other diseases.
The telemonitoring system used in this study had some unique
features that may have encouraged increased patient adherence
with the vital sign measurements. During the recording of a
vital sign, the underlying graphical data such as the pressure
trace, oscillometric waveforms, and Korotkoff sounds for NIPB
measurements were visible to patients and may have promoted
greater adherence and recording of better quality traces. Patients
were also able to view their own longitudinal records on screen
and could respond to increasing and decreasing trends in their
data. More research, however, needs to be carried out on the
relative importance of user interfaces and the quality of
biomedical instrumentation in maintaining the interest and
involvement both of patients and the CCCs.
Limitations
Limitations of this study include the reduced numbers of patients
who were monitored for the full 12 months, dropping, for
example, from 105 patients recording NIBP in the first quarter
to 61 in the fourth quarter (as reported in Multimedia Appendix
1). This drop, however, is the result of the fact that patients
began their monitoring over a period of more than 6 months
and all monitoring ended when the trial ended. As a result, some
test patients were monitored for just a little more than 6 months
and others for more than 12 months. In addition, the ability of
CCCs to support and encourage patients to continue with their
telemonitoring of vital signs was not rigorously evaluated and
was probably quite variable, although we did confirm that
generally patients supported by hospital-based specialist nurses
had higher adherence with their measurement schedules.
In a previous paper, we reported that test subjects could be
characterized as having the following primary chronic
conditions: 50% cardiac disease (mainly CHF), 30% respiratory
disease (mainly COPD), and the remaining 20% diabetes [8].
All subjects had some comorbidities. As stated earlier, in
choosing a population health approach, we analyze the total
patient cohort as a homogeneous group. We recognize, however,
that some additional insights could result from analyzing and
comparing adherence based on the primary diagnosis.
Conclusions
We have previously reported the following outcomes for this
trial: significant drop in expenditure on medical services,
reduced admissions to the hospital, and significant reduction in
hospital length of stay [8]. Data presented here suggest that
levels of adherence to long-term telemonitoring by patients with
chronic conditions support the hypothesis that longitudinal
recording of vital signs data provides powerful tools for early
identification of an exacerbation of a patient’s condition and
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